NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

Cover of Drugs and Lactation Database (LactMed)

Drugs and Lactation Database (LactMed) [Internet].

Show details

Itraconazole

Last Revision: June 3, 2019.

Estimated reading time: 1 minute

CASRN: 84625-61-6

Chemical structure

Drug Levels and Effects

Summary of Use during Lactation

No information is available on the clinical use of itraconazole during breastfeeding. However, limited data indicate that maternal itraconazole produces levels in milk that are less than the 5 mg/kg daily doses that have been recommended to treat infants. Until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. An unpublished study reported 2 healthy volunteers who each took 2 oral doses of itraconazole 200 mg 12 hours apart. Milk samples were obtained with a breast pump at 4, 24, and 48 hours after the second dose. The average milk concentrations of itraconazole were 70.2, 27.7, and 16.2 mcg/L, respectively. At 72 hours, the milk level was 20.1 mcg/L in one woman and not detectable (<5 mcg/L) in the other.[1] However, it has been noted that steady-state was probably not attained at the time of sampling, and metabolites including the active hydroxyitraconazole was not measured.[2]

Using data reported in the literature, including the above source, researchers estimated that fully breastfed infants between 3 and 12 months of age would receive 1.48% of the mother's weight-adjusted dosage of itraconazole and attain a plasma concentration of 0.77% of the mother's plasma concentration.[3]

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

References

1.
Cazzaniga EK, Chanlam A. Janssen Pharmaceutica. Personal communication to Gerald Briggs. 1996.
2.
Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation, 8th ed. Baltimore. Williams & Wilkins. 2008.
3.
McNamara PJ, Abbassi M. Neonatal exposure to drugs in breast milk. Pharm Res. 2004;21:555-66. [PubMed: 15139511]

Substance Identification

Substance Name

Itraconazole

CAS Registry Number

84625-61-6

Drug Class

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Views

Related information

Similar articles in PubMed

  • Review Terconazole[Drugs and Lactation Database (...]
    Review Terconazole
    . Drugs and Lactation Database (LactMed). 2006
  • Review Ketoconazole[Drugs and Lactation Database (...]
    Review Ketoconazole
    . Drugs and Lactation Database (LactMed). 2006
  • Review Cilostazol[Drugs and Lactation Database (...]
    Review Cilostazol
    . Drugs and Lactation Database (LactMed). 2006
  • Review Aripiprazole[Drugs and Lactation Database (...]
    Review Aripiprazole
    . Drugs and Lactation Database (LactMed). 2006
  • Review Nefazodone[Drugs and Lactation Database (...]
    Review Nefazodone
    . Drugs and Lactation Database (LactMed). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...